Leiserowitz GS - Search Results

1

Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.

Mondal T, Gaur H, Wamba BEN, Michalak AG, Stout C, Watson MR, Aleixo SL, Singh A, Condello S, Faller R, Leiserowitz GS, Bhatnagar S, Tushir-Singh J. Mondal T, et al. Among authors: leiserowitz gs. Cell Death Differ. 2023 Nov;30(11):2408-2431. doi: 10.1038/s41418-023-01229-7. Epub 2023 Oct 14. Cell Death Differ. 2023. PMID: 37838774 Free PMC article.

2

Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers.

Nguyen NT, Raetz A, Montoya D, Schilling V, Tong C, Brooks RA, Leiserowitz G, Chien J. Nguyen NT, et al. Gynecol Oncol. 2023 Nov;178:69-79. doi: 10.1016/j.ygyno.2023.09.014. Epub 2023 Oct 6. Gynecol Oncol. 2023. PMID: 37806229

3

Glycomics analysis of serum: a potential new biomarker for ovarian cancer?

Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, Li B, Liu H, Lam KS. Leiserowitz GS, et al. Int J Gynecol Cancer. 2008 May-Jun;18(3):470-5. doi: 10.1111/j.1525-1438.2007.01028.x. Epub 2007 Jul 26. Int J Gynecol Cancer. 2008. PMID: 17655680 Free PMC article.

4

Preserving sexual function in women and girls with cancer: survivorship is about more than just surviving.

Kennedy VA, Leiserowitz GS. Kennedy VA, et al. Among authors: leiserowitz gs. Am J Obstet Gynecol. 2015 Aug;213(2):119-20. doi: 10.1016/j.ajog.2015.05.006. Am J Obstet Gynecol. 2015. PMID: 26216177 No abstract available.

5

Multiple Components of Protein Homeostasis Pathway Can Be Targeted to Produce Drug Synergies with VCP Inhibitors in Ovarian Cancer.

Bastola P, Leiserowitz GS, Chien J. Bastola P, et al. Among authors: leiserowitz gs. Cancers (Basel). 2022 Jun 15;14(12):2949. doi: 10.3390/cancers14122949. Cancers (Basel). 2022. PMID: 35740614 Free PMC article.

6

Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.

Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, Lebrilla CB, An HJ, Leiserowitz GS. Hua S, et al. Among authors: leiserowitz gs. J Chromatogr A. 2013 Mar 1;1279:58-67. doi: 10.1016/j.chroma.2012.12.079. Epub 2013 Jan 11. J Chromatogr A. 2013. PMID: 23380366 Free PMC article.

7

Documentation of Infertility Risk Discussion in Cancer Patients Receiving Cancer-Directed Therapy: The UC Davis Cancer Center Experience.

McCann C, Kamiyama N, Burgess D, Usher AE, Fine J, Wilson M, Iannucci A, Leiserowitz GS, Malogolowkin M. McCann C, et al. Among authors: leiserowitz gs. J Adolesc Young Adult Oncol. 2024 Apr;13(2):288-292. doi: 10.1089/jayao.2023.0034. Epub 2023 Aug 22. J Adolesc Young Adult Oncol. 2024. PMID: 37610879

8

Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.

An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB. An HJ, et al. Among authors: leiserowitz gs. J Proteome Res. 2006 Jul;5(7):1626-35. doi: 10.1021/pr060010k. J Proteome Res. 2006. PMID: 16823970

9

Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.

Ruhaak LR, Kim K, Stroble C, Taylor SL, Hong Q, Miyamoto S, Lebrilla CB, Leiserowitz G. Ruhaak LR, et al. J Proteome Res. 2016 Mar 4;15(3):1002-10. doi: 10.1021/acs.jproteome.5b01071. Epub 2016 Feb 24. J Proteome Res. 2016. PMID: 26813784 Free PMC article.

10

Managing ovarian masses during pregnancy.

Leiserowitz GS. Leiserowitz GS. Obstet Gynecol Surv. 2006 Jul;61(7):463-70. doi: 10.1097/01.ogx.0000224614.51356.b7. Obstet Gynecol Surv. 2006. PMID: 16787549 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page